Pensions & Investments Logo
ETF Exchange > BBC ETF

BBC - ETF Fact Sheet

Virtus LifeSci Biotech Clinical Trials ETF - USD

Fund Identification

Ticker

BBC

ISIN

US26923G3011

Main Metrics

Price

$39.56

Expense Ratio

0.79%

AuM

$33.63M

Tracking Difference

-2.13%

Ratings

Trackinsight rating

ESG Consensus®

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise

Official Investment Strategy

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.

BBC's historical prices, performance, and flows

-8.0-6.0-4.0-2.00.02.0%
1m returns
-7.04%
1m flows
-$2M
* Net total returns
All data as of 27 March 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all BBC data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

BBC's characteristics

Manager statistics

22 funds, $2.71Bn in AUM

Benchmark

LifeSci Biotechnology Clinical Trials Total Return Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing

Meets ESG criteria

No
BBC's exposure

Countries

USA
89.47%
Other
10.53%

Sectors

Health Care
66.33%
Other
33.67%

Top 5 holdings

Other
32.43%
CORVUS PHARMACEUTICALS INC
1.60%
REZOLUTE INC
1.38%
VENTYX BIOSCIENCES
1.32%
ARCELLX
1.23%
Total holdings
81
Total weight of top 5
37.95%
2.0%